CRIS Current Research Information System

PALMERINI, EMANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.707
AS - Asia 8.450
EU - Europa 5.917
SA - Sud America 556
AF - Africa 421
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 10
Totale 25.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.551
VN - Vietnam 2.489
SG - Singapore 2.371
CN - Cina 1.651
GB - Regno Unito 1.274
IT - Italia 1.118
DE - Germania 919
HK - Hong Kong 787
SE - Svezia 664
BR - Brasile 406
FR - Francia 399
IN - India 384
RU - Federazione Russa 317
IE - Irlanda 240
NL - Olanda 164
JP - Giappone 161
FI - Finlandia 138
ZA - Sudafrica 138
BD - Bangladesh 126
UA - Ucraina 113
KR - Corea 112
CH - Svizzera 105
EE - Estonia 95
CI - Costa d'Avorio 94
ES - Italia 82
TG - Togo 79
CA - Canada 71
JO - Giordania 67
AT - Austria 66
BG - Bulgaria 60
AR - Argentina 53
PH - Filippine 50
ID - Indonesia 44
BE - Belgio 42
TH - Thailandia 42
PL - Polonia 40
MX - Messico 36
IQ - Iraq 32
EC - Ecuador 31
AU - Australia 24
MA - Marocco 24
EG - Egitto 23
CO - Colombia 18
SC - Seychelles 18
MY - Malesia 17
GR - Grecia 15
PK - Pakistan 15
SA - Arabia Saudita 13
TR - Turchia 13
CL - Cile 12
TW - Taiwan 12
UZ - Uzbekistan 12
ET - Etiopia 10
RO - Romania 10
AL - Albania 9
KE - Kenya 9
CR - Costa Rica 8
LB - Libano 8
PE - Perù 8
PY - Paraguay 8
BZ - Belize 7
IR - Iran 7
JM - Giamaica 7
NO - Norvegia 7
UY - Uruguay 7
VE - Venezuela 7
DO - Repubblica Dominicana 6
LT - Lituania 6
NG - Nigeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BO - Bolivia 5
HU - Ungheria 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
HR - Croazia 4
KW - Kuwait 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
AM - Armenia 2
BH - Bahrain 2
FJ - Figi 2
GA - Gabon 2
HT - Haiti 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
Totale 25.054
Salva come PNG Salva come JPEG
Città #
Singapore 1.640
Southend 1.104
Ashburn 1.074
Fairfield 861
Chandler 761
Hong Kong 757
San Jose 659
Ho Chi Minh City 566
Hanoi 552
Woodbridge 463
Wilmington 416
Santa Clara 381
Seattle 371
Houston 349
Ann Arbor 346
Princeton 332
Cambridge 292
Beijing 275
Dong Ket 261
Dublin 238
Boardman 227
Lauterbourg 164
Frankfurt am Main 163
Bologna 148
Hefei 146
Tokyo 133
Los Angeles 127
Helsinki 115
Nanjing 113
Westminster 110
Padova 104
Buffalo 97
Abidjan 94
Seoul 90
Council Bluffs 87
Bern 86
New York 83
Turin 80
Lomé 79
Berlin 78
Dallas 78
Milan 76
Da Nang 73
Redmond 69
Amman 66
Haiphong 62
Redondo Beach 61
San Diego 61
Saint Petersburg 58
Bremen 57
Sofia 52
São Paulo 52
Medford 48
Shenyang 47
Des Moines 45
Rome 45
Falls Church 43
Jinan 43
Munich 43
Brussels 40
Guangzhou 40
Shanghai 40
Dearborn 39
Chicago 38
Hebei 38
Vienna 36
Nanchang 34
Changsha 33
Hải Dương 28
Düsseldorf 27
Nuremberg 27
Biên Hòa 26
Jacksonville 26
Atlanta 25
Falkenstein 25
Amsterdam 24
Can Tho 24
Quận Bình Thạnh 24
San Francisco 24
Phoenix 23
Zhengzhou 23
Lacchiarella 22
London 22
Orem 22
Paris 22
Florence 21
Hangzhou 21
Norwalk 21
Warsaw 21
Thái Nguyên 20
Tianjin 20
Cairo 19
Ha Long 19
Jiaxing 19
Brooklyn 18
Toronto 17
Bari 16
Bengaluru 16
Jakarta 16
Redwood City 16
Totale 16.133
Salva come PNG Salva come JPEG
Nome #
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 467
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 376
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 319
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 311
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 290
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 274
A Mass with High Uptake of Fluorodeoxyglucose on Positron Emission Tomography 270
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 252
Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? 237
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β 232
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 230
Delaying surgery for patients with a previous SARS-CoV-2 infection 227
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 224
Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience 219
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 217
Advances in treatment for tenosynovial giant cell tumors 215
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 209
Predictive factors of histologic response to primary chemotherapy in patients with ewing sarcoma 206
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 203
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 202
Osteosarcoma follow-up: chest X-ray or computed tomography? 200
CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338 200
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 200
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 199
SELNET clinical practice guidelines for soft tissue sarcoma and GIST 199
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 196
Case report: temozolomide induced partial response in a primary diffuse leptomeningeal gliomatosis patient. 195
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study 194
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors 192
Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma 190
Pazopanib in relapsed osteosarcoma patients: report on 15 cases 189
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age 185
Chondrosarcomas revisited. 183
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 182
Diagnosis and prognosis for the Ewing family of tumors 182
ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2) 178
Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors 177
Advanced chondrosarcomas: Role of chemotherapy and survival 177
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma 176
Eribulin in advanced liposarcoma and leiomyosarcoma 176
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 175
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 172
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 171
Emerging therapeutic targets for synovial sarcoma 169
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs 168
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 167
High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. 166
Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma 166
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study 166
Phase ii study on lapatinib in advanced egfr-positive chordoma 165
Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. 165
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 165
Synovial sarcoma: Is chemotaxis important to tumor progression? 163
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 163
Spontaneous regression of lung metastasis from osteosarcoma: A case report 162
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence. 162
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 161
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 161
A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. 160
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 159
High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. 159
Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati) 157
The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the italian Rizzoli experience. Impact on the future. 156
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 155
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ 155
Osteosarcoma: Tra presente e futuro 154
Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma 154
Periosteal osteosarcoma: a single-institution experience. 154
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 154
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? 154
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 153
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 151
The natural history of advanced inoperable central chondrosarcoma 150
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 150
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade 150
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 148
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS). 148
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 147
Analysis of risk factors for central venous catheter-related complications: a prospective observational study in pediatric patients with bone sarcomas 147
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 146
Non-surgical treatment of chondrosarcoma: Current concepts and future perspectives 146
Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. 144
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 143
Pazopanib in metastatic osteosarcoma patients: Report of 9 cases treated off label at Rizzoli Orthopedic Institute 143
Metastatic spread to bone: The role of chemotherapy 142
Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). 142
Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution 142
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 140
Two doses of NGR-hTNF (N) given alone or in combination with doxorubicin (D) in soft tissue sarcomas (STS). 139
Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma 139
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial 139
Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. 138
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 138
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? 138
Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution 137
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 137
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-institutional case series. 137
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial 136
Palliative embolisation for advanced bone sarcomas. 134
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts 134
Totale 18.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.826 231 70 166 150 326 160 68 251 164 223 489 528
2022/20233.336 356 470 247 423 225 238 121 188 525 125 207 211
2023/2024792 51 154 65 65 48 91 56 50 25 62 44 81
2024/20253.577 154 608 273 245 582 179 205 94 67 224 131 815
2025/20268.956 855 876 647 539 880 584 1.005 544 1.779 647 321 279
2026/2027177 177 0 0 0 0 0 0 0 0 0 0 0
Totale 25.579